UBS analyst Kevin Caliendo lowered the firm’s price target on Henry Schein (HSIC) to $70 from $75 and keeps a Neutral rating on the shares. Henry Schein reported an EPS miss, but reiterated its guidance, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC:
- Henry Schein price target lowered to $78 from $86 at Barrington
- Cautious Hold on Henry Schein Amid EPS Shortfall and Uncertain Strategic Partnerships
- Henry Schein backs FY25 adjusted EPS $4.80-$4.94, consensus $4.85
- Henry Schein reports Q2 adjusted EPS $1.10, consensus $1.19
- Is HSIC a Buy, Before Earnings?